InvestorsHub Logo
Followers 137
Posts 10050
Boards Moderated 0
Alias Born 04/13/2007

Re: lakers17 post# 34360

Saturday, 11/21/2020 4:57:00 AM

Saturday, November 21, 2020 4:57:00 AM

Post# of 35961
Gilead Sciences has a $75 billion market cap. NSPX has a $2 million market cap. Remedesivir works for many other indications and is a very popular drug. NSPX with their adenosine receptor catalog will be competing in the same space.